Simplified Summary
hMG is a preparation derived from the urine of postmenopausal women containing a mixture of FSH and LH activity. In preclinical reproductive biology research, it has been used to study the combined effects of FSH and LH receptor stimulation on follicular development, granulosa cell biology, and ovarian function in animal model systems. Its combined FSH/LH activity profile makes it useful for research models requiring coordinated gonadotropin stimulation.
Key Findings Reported in Preclinical Models
- Folliculogenesis stimulation in preclinical ovarian biology models through FSH receptor-mediated granulosa cell activation.
- Combined FSH + LH receptor engagement effects on follicular steroidogenesis characterised in cell-based and animal model systems.
- Superovulation induction in preclinical rodent model systems using hMG for reproductive biology research applications.
Introduction
Gonadotropin research has been fundamental to reproductive endocrinology, with FSH and LH characterised as the central regulators of gonadal function in both sexes. hMG provides a combined FSH/LH preparation used in preclinical research to study the coordinated effects of both gonadotropins on reproductive tissue biology, follicular development, and the HPG axis in laboratory settings.
Research Applications
- Reproductive endocrinology research examining combined FSH and LH receptor stimulation in ovarian biology model systems.
- Folliculogenesis and granulosa cell biology research in preclinical models.
- Superovulation and embryology research using hMG for controlled ovarian stimulation in animal model systems.
For research use only. Capital Peptides products are not approved by the TGA for therapeutic use. By purchasing you confirm you are a licensed research entity or qualified professional.